{"DataElement":{"publicId":"2200959","version":"1","preferredName":"Person Specimen Malignant Neoplasm Research Consent Ind-2","preferredDefinition":"the yes/no indicator related to the patient's consent regarding a specimen.","longName":"PER_SP_CA_RS_CO_IND","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2200958","version":"1","preferredName":"Person Specimen Malignant Neoplasm Research Consent","preferredDefinition":"information related to the consent or permission from a person to use a portion of blood, tissue, or other substance from the body in cancer research, the systematic investigation of the nature of diseases in which abnormal cells divide without control.","longName":"PER_SPEC_CA_RES_CON","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2236731","version":"1","preferredName":"Person","preferredDefinition":"A human being.","longName":"C25190","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Person","conceptCode":"C25190","definition":"A human being.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9FC6DF7-66EB-4CAB-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-20","endDate":null,"createdBy":"UMLLOADER_MAGE","dateCreated":"2005-06-20","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2782577","version":"1","preferredName":"Specimen Malignant Neoplasm Research Consent","preferredDefinition":"A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis.:A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004:Systematic investigation into a subject in order to discover facts, to establish or revise a theory, or to develop a plan of action based on the facts discovered.:Permission to do something.","longName":"C19157:C9305:C15319:C25460","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Specimen","conceptCode":"C19157","definition":"A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Research","conceptCode":"C15319","definition":"Systematic investigation into a subject in order to discover facts, to establish or revise a theory, or to develop a plan of action based on the facts discovered.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Consent","conceptCode":"C25460","definition":"Permission to do something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"568BAAEE-608D-110F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-09-10","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-09-10","modifiedBy":"ONEDATA","dateModified":"2008-09-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F1F709E4-C8AC-01E3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-10","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-03-10","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3506068","version":"1","preferredName":"Yes No Indicator","preferredDefinition":"The preferred Value Domain to indicate a question with permissible values of yes/no.","longName":"YES_NO_IND","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"No","valueDescription":"No","ValueMeaning":{"publicId":"3197154","version":"1","preferredName":"No","longName":"3197154","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-55AD-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":"2022.12.28 Alt VM added per ticket request CADSR0001837. aj","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75C2-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"},{"value":"Yes","valueDescription":"Yes","ValueMeaning":{"publicId":"3197153","version":"1","preferredName":"Yes","longName":"3197153v1.00","preferredDefinition":"The affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-558A-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75CC-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"3502157","version":"1","preferredName":"Yes No Indicator Value Domains","preferredDefinition":"Conceptual domain that includes value meanings to be used for Indicator Value Meanings such as Yes, No, Unknown, No Applicable","longName":"YES_NO_IND_VD","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C377DE0C-8C3E-DCA8-E040-BB89AD431B6D","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CURTIST","dateCreated":"2012-06-27","modifiedBy":"CURTIST","dateModified":"2012-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2421125","version":"1","preferredName":"Ind-2","preferredDefinition":"A caDSR representation term that is used to indicate a question with permissible values of yes/no","longName":"C38147","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes or No Response","conceptCode":"C38147","definition":"A response or indicator that can have a value of either yes or no.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RETIRED ARCHIVED","registrationStatus":"Retired","id":"0303DF01-F4B4-15EC-E044-0003BA3F9857","latestVersionIndicator":"No","beginDate":"2005-10-18","endDate":"2016-04-27","createdBy":"SHIDED","dateCreated":"2005-10-18","modifiedBy":"TAYLORT","dateModified":"2020-10-03","changeDescription":"10.3.20 TL changed WFS from RETIRED PHASED OUT to RETIRED ARCHIVED. Changed Workflow Status DBW 04-27-2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"C37A1BEB-75AE-B6C9-E040-BB89AD434179","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"TSESU","dateModified":"2023-08-16","changeDescription":"8/29/17 tt added CSI per Round 5 finalization task. 3/12/17 jk added Standard reg status; ownership transfered from CTEP to NCI Standards with concurrence of CTEP/Brian Campbell. jk","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811832","version":"1","longName":"Lung","context":"CTEP"},{"publicId":"2811835","version":"1","longName":"Melanoma","context":"CTEP"},{"publicId":"2811871","version":"1","longName":"Colorectal","context":"CTEP"},{"publicId":"10000607","version":"1","longName":"Sarcoma","context":"CTEP"},{"publicId":"2811907","version":"1","longName":"Bladder","context":"CTEP"},{"publicId":"2811831","version":"1","longName":"Breast","context":"CTEP"},{"publicId":"2811908","version":"1","longName":"Gynecologic","context":"CTEP"},{"publicId":"2811909","version":"1","longName":"Leukemia","context":"CTEP"},{"publicId":"2811910","version":"1","longName":"Prostate","context":"CTEP"},{"publicId":"2811911","version":"1","longName":"Upper GI","context":"CTEP"},{"publicId":"2811912","version":"1","longName":"Head and Neck","context":"CTEP"},{"publicId":"2811913","version":"1","longName":"Lymphoma","context":"CTEP"},{"publicId":"2811949","version":"1","longName":"Brain","context":"CTEP"},{"publicId":"2811950","version":"1","longName":"Multiple Myeloma","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811954","version":"1","longName":"Eligibility Criteria","context":"CTEP"}]},{"publicId":"2008594","version":"2.31","longName":"Trial Type Usages (CDE Disease Committees)","context":"CTEP","ClassificationSchemeItems":[{"publicId":"10000362","version":"1","longName":"AML Prev Untreated","context":"CTEP"},{"publicId":"3298577","version":"1","longName":"Hepatobiliary","context":"CTEP"},{"publicId":"10000462","version":"1","longName":"Muscle Invasive Blad","context":"CTEP"},{"publicId":"10000001","version":"1","longName":"NSCLC Advanced","context":"CTEP"},{"publicId":"2811931","version":"1","longName":"NSCLC Stage I-III","context":"CTEP"}]},{"publicId":"2008608","version":"1","longName":"Phase","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811890","version":"1","longName":"Phase III","context":"CTEP"}]},{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]},{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"4171054","version":"1","longName":"RTOG-0912","context":"NRG"},{"publicId":"4171051","version":"1","longName":"RTOG-1016","context":"NRG"},{"publicId":"4104935","version":"1","longName":"RTOG-1221","context":"NRG"},{"publicId":"4171063","version":"1","longName":"RTOG-0534","context":"NRG"},{"publicId":"4104933","version":"1","longName":"RTOG-1308","context":"NRG"},{"publicId":"4104993","version":"1","longName":"RTOG-1112","context":"NRG"},{"publicId":"4171065","version":"1","longName":"RTOG-0924","context":"NRG"},{"publicId":"4104994","version":"1","longName":"RTOG-1201","context":"NRG"},{"publicId":"4104937","version":"1","longName":"RTOG-1306","context":"NRG"},{"publicId":"4171133","version":"1","longName":"RTOG-1114","context":"NRG"},{"publicId":"4171053","version":"1","longName":"RTOG-1008","context":"NRG"},{"publicId":"4171132","version":"1","longName":"RTOG-1119","context":"NRG"},{"publicId":"4171134","version":"1","longName":"RTOG-1122","context":"NRG"},{"publicId":"4104934","version":"1","longName":"RTOG-1216","context":"NRG"},{"publicId":"4171064","version":"1","longName":"RTOG-0815","context":"NRG"},{"publicId":"4171135","version":"1","longName":"RTOG-1205","context":"NRG"},{"publicId":"4171062","version":"1","longName":"RTOG-1005","context":"NRG"},{"publicId":"4171052","version":"1","longName":"RTOG-0920","context":"NRG"},{"publicId":"4058010","version":"1","longName":"Head and Neck","context":"NRG"},{"publicId":"4171066","version":"1","longName":"RTOG-0926","context":"NRG"},{"publicId":"4171058","version":"1","longName":"RTOG-1106","context":"NRG"},{"publicId":"4171056","version":"1","longName":"RTOG-0839","context":"NRG"},{"publicId":"4171060","version":"1","longName":"RTOG-0848","context":"NRG"},{"publicId":"4171059","version":"1","longName":"RTOG-0724","context":"NRG"},{"publicId":"4171061","version":"1","longName":"RTOG-1010","context":"NRG"}]}],"AlternateNames":[{"name":"PER_SP_CA_RS_CO_IND","type":"USED_BY","context":"CTEP"},{"name":"AECC","type":"USED_BY","context":"AECC"},{"name":"ECOG-ACRIN","type":"USED_BY","context":"ECOG-ACRIN"},{"name":"PER_SP_CA_RS_CO_IND","type":"USED_BY","context":"Alliance"},{"name":"PER_SP_CA_RS_CO_IND","type":"USED_BY","context":"NRG"},{"name":"COG","type":"USED_BY","context":"COG"}],"ReferenceDocuments":[{"name":"My specimens may be kept for","type":"Preferred Question Text","description":"My specimens may be kept for use in research to learn about, prevent, treat, or cure cancer.","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"Patient's Initial Consent given for specimen kept for future use in research to learn about, prevent, or treat cancer","url":null,"context":"CTEP"},{"name":"CRF Text2","type":"Alternate Question Text","description":"Have you obtained the patient's consent for his or her specimens to be used for research to learn about, prevent or treat cancer?","url":null,"context":"CTEP"},{"name":"CRF Text4","type":"Alternate Question Text","description":"Patient has given permission to keep sample(s) for use in future research to learn about, prevent, or treat cancer","url":null,"context":"CTEP"},{"name":"CRF3","type":"Alternate Question Text","description":"Did this patient provide written consent to give tissue specimen(s) for research","url":null,"context":"CTEP"},{"name":"CRF Text3","type":"Alternate Question Text","description":"Have you obtained the patient's consent for his or her tissue to be used for research to learn about, prevent or treat cancer?","url":null,"context":"CTEP"},{"name":"CRF Text8","type":"Alternate Question Text","description":"Patient has given permission to keep tissue sample(s) for use in future research to learn about, prevent, or treat cancer","url":null,"context":"CTEP"},{"name":"CRF Text9","type":"Alternate Question Text","description":"May your coded samples and related coded information be kept for use in research to learn about, prevent, find or treat cancer?  This may also include research on inherited traits (genes passed on in families).","url":null,"context":"CTEP"},{"name":"CRF Text1","type":"Alternate Question Text","description":"Have you obtained the patient's consent for his or her tissue to be kept for use in research to learn about, prevent, treat or cure cancer","url":null,"context":"CTEP"},{"name":"CRF Text7","type":"Alternate Question Text","description":"Have you obtained the patient's consent for her tissue to be kept for use in research to learn about, prevent, treat, or cure cancer?","url":null,"context":"CTEP"},{"name":"CRF Text6","type":"Alternate Question Text","description":"Patient has given permission to store and use his/her tissue samples for use in future research to learn about, prevent, or treat cancer","url":null,"context":"CTEP"},{"name":"CRF Text5","type":"Alternate Question Text","description":"Did patient/parent/guardian agree to have patients' specimen banked for use in research to learn about, prevent, or treat cancer","url":null,"context":"CTEP"},{"name":"CRF Text14","type":"Alternate Question Text","description":"My coded samples and related coded information may be kept for use in research to learn about, prevent, find or treat cancer.  This may also include research on inherited traits (genes passed on in families).","url":null,"context":"CTEP"},{"name":"CRF Text10","type":"Alternate Question Text","description":"My coded samples and related coded information may be used to learn about, prevent, find or treat my type of cancer. This may also include research on inherited traits (genes passed on in families)","url":null,"context":"CTEP"},{"name":"CRF Text15","type":"Alternate Question Text","description":"My specimens may be kept for future unknown use in research to learn about, prevent, treat, or cure cancer","url":null,"context":"CTEP"},{"name":"CRF Text18","type":"Alternate Question Text","description":"Patient has given permission for NCCTG/Alliance to store and use his/her sample(s) for use in future research to learn about, prevent, or treat cancer","url":null,"context":"CTEP"},{"name":"CRF Text11","type":"Alternate Question Text","description":"Patient has given permission for Alliance to store and use his/her tissue sample(s) for use in future research to learn about, prevent, or treat cancer","url":null,"context":"CTEP"},{"name":"CRF Text17","type":"Alternate Question Text","description":"Patient has given permission for Alliance/NCCTG to store and use his/her blood and tissue sample(s) for use in future research to learn about, prevent, or treat cancer","url":null,"context":"CTEP"},{"name":"9177 Inclusion Criteria","type":"Alternate Question Text","description":"Did the patient consent to Tissue Procuement for cancer research","url":null,"context":"CTEP"},{"name":"CRF Text12","type":"Alternate Question Text","description":"Patient has given permission to store and use tissue sample(s) for use in future research to learn about, prevent, or treat cancer","url":null,"context":"CTEP"},{"name":"CRF Text16","type":"Alternate Question Text","description":"Patient has given permission to store and use his/her sample(s) for use in future research to learn about, prevent, or treat cancer.","url":null,"context":"CTEP"},{"name":"CRF Text13","type":"Alternate Question Text","description":"Patient has given permission to store and use his/her tissue sample(s) for use in future research to learn about, prevent, or treat cancer","url":null,"context":"CTEP"},{"name":"CRF Text19","type":"Alternate Question Text","description":"My tumor tissue may be kept for use in research to learn about, prevent, or treat cancer.","url":null,"context":"CTEP"},{"name":"CRF Text20","type":"Alternate Question Text","description":"Patient has given permission to have blood sample(s) collected on both Cycle 1 Day 2 and after completion of chemotherapy for research purposes.  The patient's coded samples and related coded information may be used to learn about, prevent, find or treat the patient's type of cancer.  This may also include research on inherited traits (genes passed on in families).","url":null,"context":"CTEP"},{"name":"ECOG CRF 1","type":"Alternate Question Text","description":"Previously collected specimens can be used for other research studies about cancer.","url":null,"context":"ECOG-ACRIN"},{"name":"CRF Text21","type":"Alternate Question Text","description":"Have you obtained the patient's consent for his specimens to be used for research to learn about, prevent or treat cancer?","url":null,"context":"CTEP"},{"name":"CRF Text22","type":"Alternate Question Text","description":"Have you obtained the patient's consent for his specimens to be used for medical research?","url":null,"context":"CTEP"},{"name":"CRF Text23","type":"Alternate Question Text","description":"Patient has given permission to have blood collected after surgery during follow-up period of study.  The patient's coded sample(s) and related coded information may be used to learn about, prevent, find or treat the patient's type of cancer.  This may also include research on inherited traits (genes passed on in families).","url":null,"context":"Alliance"},{"name":"CRF Text24","type":"Alternate Question Text","description":"Patient has given permission to have additional blood collected after surgery during follow-up period of study.  The patient's coded sample(s) and related coded information may be used to learn about, prevent, find or treat the patient's type of cancer.  This may also include research on inherited traits (genes passed on in families).","url":null,"context":"Alliance"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"Was consent given for patient's tissue and/or blood samples to be kept (banked) for use in research to learn about, prevent, or treat cancer or other health problems (for example: diabetes, Alzheimer's disease, or heart disease)?","url":null,"context":"COG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F1F73FA7-EE19-01F3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-10","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-03-10","modifiedBy":"TYRRELLM","dateModified":"2023-07-21","changeDescription":"Replaced VD Patient Consent Ind-2 2018303v1.0 with VD ID#3506068 - Yes No Indicator - dbw","administrativeNotes":"7/21/23 removed special character from AQTs_mmt\r\n7/20/2022: fixed the box symbol in AQT.wz","unresolvedIssues":null,"deletedIndicator":"No"}}